在喘中发现与PANoptosis相关的lncRNAs的鉴定和分子机制
Yanzhi Cui1, Shuang Wei2, Lei Liang1
1Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
Biotechnology and applied biochemistry
|October 12, 2025
概括
研究人员确定了与PANoptosis相关的四种长非编码RNA (lncRNA),这些RNA可以作为喘的诊断生物标志物. 这些与PANoptosis相关的lncRNAs在喘患者中表现异常,为疾病机制提供了新的见解.
科学领域:
- 生物医学研究的研究.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 喘是一种慢性呼吸道疾病,具有复杂的发病因子.
- 新发现的细胞死亡途径PANoptosis已成为喘的重要因素.
- 长非编码RNAs (lncRNAs) 越来越多地被认为是它们在各种疾病中的作用,包括喘.
研究的目的:
- 为了识别与喘中的PANoptosis相关的长非编码RNA (lncRNAs).
- 评估这些与PANoptosis相关的lncRNAs作为喘生物标志物的诊断潜力.
- 探索涉及这些lncRNAs在喘发病过程中的潜在分子机制.
主要方法:
- 分析了两个公共喘数据集 (GSE165934和GSE195599).
- 使用逻辑回归和 LASSO 模型对诊断 lncRNA 的查.
- 竞争性内源RNA (ceRNA) 网络的构建和免疫微环境的评估.
主要成果:
- 四种差异表达的lncRNAs (LUCAT1,RC3H1-IT1,FAM157A,TTN-AS1) 被确定为喘中PANoptosis的诊断生物标志物.
- 与对照人群相比,喘样本显示免疫细胞组成和信号通路的显著变化.
- 三种已识别的lncRNAs主要局部在细胞质中,并且它们的表达在喘样本中显著减少.
结论:
- 这项研究提供了第一个证据,将与PANoptosis相关的lncRNA与喘联系起来.
- 已识别的lncRNAs (LUCAT1,RC3H1-IT1,FAM157A,TTN-AS1) 显示出可能成为喘的新型诊断生物标志物.
- 这些发现为喘病原体提供了新的见解,并可能为开发有针对性的治疗策略提供信息.
更多相关视频
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
8.1K
06:08Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
2.4K
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
02:39lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.1K
01:29Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K